Iismaa Siiri E, Kaidonis Xenia, Nicks Amy M, Bogush Nikolay, Kikuchi Kazu, Naqvi Nawazish, Harvey Richard P, Husain Ahsan, Graham Robert M
1Victor Chang Cardiac Research Institute, Sydney, NSW 2010 Australia.
2University of New South Wales, Kensington, NSW 2033 Australia.
NPJ Regen Med. 2018 Feb 23;3:6. doi: 10.1038/s41536-018-0044-5. eCollection 2018.
Stimulating regeneration of complex tissues and organs after injury to effect complete structural and functional repair, is an attractive therapeutic option that would revolutionize clinical medicine. Compared to many metazoan phyla that show extraordinary regenerative capacity, which in some instances persists throughout life, regeneration in mammalians, particularly humans, is limited or absent. Here we consider recent insights in the elucidation of molecular mechanisms of regeneration that have come from studies of tissue homeostasis and injury repair in mammalian tissues that span the spectrum from little or no self-renewal, to those showing active cell turnover throughout life. These studies highlight the diversity of factors that constrain regeneration, including immune responses, extracellular matrix composition, age, injury type, physiological adaptation, and angiogenic and neurogenic capacity. Despite these constraints, much progress has been made in elucidating key molecular mechanisms that may provide therapeutic targets for the development of future regenerative therapies, as well as previously unidentified developmental paradigms and windows-of-opportunity for improved regenerative repair.
刺激损伤后复杂组织和器官的再生以实现完整的结构和功能修复,是一种极具吸引力的治疗选择,它将彻底改变临床医学。与许多具有非凡再生能力(在某些情况下这种能力会持续一生)的后生动物门相比,哺乳动物尤其是人类的再生能力有限或缺乏。在这里,我们探讨了近期在阐明再生分子机制方面的见解,这些见解来自对哺乳动物组织中组织稳态和损伤修复的研究,这些组织涵盖了从几乎没有或没有自我更新能力到终生具有活跃细胞更新能力的范围。这些研究突出了限制再生的多种因素,包括免疫反应、细胞外基质组成、年龄、损伤类型、生理适应以及血管生成和神经生成能力。尽管存在这些限制,但在阐明关键分子机制方面已取得了很大进展,这些机制可能为未来再生疗法的开发提供治疗靶点,同时也揭示了以前未被识别的发育模式和改善再生修复的机会窗口。